(Q37922765)

25 August 2017

1 reference

title

Neuropsychiatric manifestations in systemic lupus erythematosus: epidemiology, pathophysiology and management (English)

1 reference

systemic lupus erythematosus

25 August 2017

1 reference

1 reference

1 reference

1 reference

Mariana Postal

1

1 reference

25 August 2017

Lilian T L Costallat

series ordinal

2

1 reference

25 August 2017

Simone Appenzeller

series ordinal

3

1 reference

25 August 2017

publication date

1 September 2011

1 reference

25 August 2017

1 reference

25 August 2017

volume

25

1 reference

25 August 2017

issue

9

1 reference

25 August 2017

page(s)

721-736

1 reference

https://scigraph.springernature.com/pub.10.2165/11591670-000000000-00000

25 August 2017

exact match

0 references

cites work

The 1982 revised criteria for the classification of systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.2165%2F11591670-000000000-00000

The prevalence of neuropsychiatric syndromes in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591670-000000000-00000

Pathogenesis, diagnosis and management of neuropsychiatric SLE manifestations

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591670-000000000-00000

Neuropsychiatric syndromes in lupus: prevalence using standardized definitions.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591670-000000000-00000

Neuropsychiatric manifestations in pediatric systemic lupus erythematosus: a 20-year study.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591670-000000000-00000

Abnormal olfactory function demonstrated by manganese-enhanced MRI in mice with experimental neuropsychiatric lupus

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591670-000000000-00000

Auditory function in patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591670-000000000-00000

Predictors of neuropsychiatric damage in systemic lupus erythematosus: data from the Maryland lupus cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591670-000000000-00000

Outcome of neuropsychiatric systemic lupus erythematosus within a defined Swedish population: increased morbidity but low mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591670-000000000-00000

Impact of memory impairment on employment status in persons with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591670-000000000-00000

Employment and work disability in systemic lupus erythematosus: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591670-000000000-00000

Cognitive impairment and employment status in systemic lupus erythematosus: a prospective longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591670-000000000-00000

Prospective study of neuropsychiatric events in systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591670-000000000-00000

SF-36 summary and subscale scores are reliable outcomes of neuropsychiatric events in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591670-000000000-00000

EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591670-000000000-00000

Epileptic seizures in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591670-000000000-00000

Psychosis due to systemic lupus erythematosus: characteristics and long-term outcome of this rare manifestation of the disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591670-000000000-00000

Management of neuropsychiatric lupus

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591670-000000000-00000

Clinical implications of migraine in systemic lupus erythematosus: relation to cumulative organ damage

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591670-000000000-00000

The ACR classification criteria for headache disorders in SLE fail to classify certain prevalent headache types

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591670-000000000-00000

Validity of the new American College of Rheumatology criteria for neuropsychiatric lupus syndromes: a population-based evaluation.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591670-000000000-00000

Clinical features and outcome of neuropsychiatric lupus in Chinese: analysis of 240 hospitalized patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591670-000000000-00000

Neurologic manifestations of systemic lupus erythematosus in children and adults

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591670-000000000-00000

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591670-000000000-00000

Psychosocial research on systemic lupus erythematosus: a literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591670-000000000-00000

Prevalence of mood and anxiety disorders in women with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591670-000000000-00000

Third cranial nerve palsy or pseudo 3rd nerve palsy of myasthenia gravis? A challenging diagnosis in systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591670-000000000-00000

Cognitive impairment in systemic lupus erythematosus: a follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591670-000000000-00000

Hippocampal atrophy in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591670-000000000-00000

A prospective study of psychiatric disorder and cognitive function in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591670-000000000-00000

Neuropsychological function in systemic lupus erythematosus: a five-year longitudinal study.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591670-000000000-00000

Brain magnetic resonance imaging in newly diagnosed systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591670-000000000-00000

Clinical and neuropathological findings in systemic lupus erythematosus: the role of vasculitis, heart emboli, and thrombotic thrombocytopenic purpura.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591670-000000000-00000

Central nervous system involvement in systemic lupus erythematosus: A review of neuropathologic findings in 57 cases, 1955–1977

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591670-000000000-00000

The pathogenesis of central nervous system manifestations of systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591670-000000000-00000

The blood-brain barrier in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591670-000000000-00000

Pathology and pathogenesis of vascular injury in systemic lupus erythematosus. Interactions of inflammatory cells and activated endothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591670-000000000-00000

Voxel-based morphometry of brain SPECT can detect the presence of active central nervous system involvement in systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591670-000000000-00000

Evidence of reversible axonal dysfunction in systemic lupus erythematosus: a proton MRS study

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591670-000000000-00000

Antiserum to brain gangliosides produces recurrent epileptiform activity

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591670-000000000-00000

Soluble adhesion molecule levels, neuropsychiatric lupus and lupus-related damage.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591670-000000000-00000

Interferon-alpha in lupus psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591670-000000000-00000

Increased serum matrix metalloproteinase 9 levels in systemic lupus erythematosus patients with neuropsychiatric manifestations and brain magnetic resonance imaging abnormalities

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591670-000000000-00000

Accuracy of cerebrospinal fluid IL-6 testing for diagnosis of lupus psychosis. A multicenter retrospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591670-000000000-00000

Glutamate receptor biology and its clinical significance in neuropsychiatric systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591670-000000000-00000

Neurometabolite markers of cerebral injury in the antiphospholipid antibody syndrome of systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591670-000000000-00000

Antiphospholipid antibodies in an in vivo thrombosis model in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591670-000000000-00000

Acute transverse myelitis and antiphospholipid antibodies in lupus. No evidence for anticoagulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591670-000000000-00000

Clinical and serological associations of ribosomal P autoantibodies in systemic lupus erythematosus: prospective evaluation in a large cohort of Italian patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591670-000000000-00000

The role of measurement of serum autoantibodies in prediction of pediatric neuropsychiatric systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591670-000000000-00000

Prevalence of depressive and anxiety disorders in systemic lupus erythematosus and their association with anti-ribosomal P antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591670-000000000-00000

Autoantibodies and neuropsychiatric events at the time of systemic lupus erythematosus diagnosis: results from an international inception cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591670-000000000-00000

The effect of antisynaptosomal plasma membrane antibodies on memory

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591670-000000000-00000

Selective impairment of learning and blockade of long-term potentiation by an N-methyl-D-aspartate receptor antagonist, AP5

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591670-000000000-00000

Glutamate signalling in non-neuronal tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591670-000000000-00000

A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591670-000000000-00000

Anti-N-methyl-D-aspartate receptor antibodies, cognitive dysfunction, and depression in systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591670-000000000-00000

Neuropsychiatric disturbances in SLE are associated with antibodies against NMDA receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591670-000000000-00000

Selective involvement of the amygdala in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591670-000000000-00000

Relationship between serum NR2a antibodies and cognitive dysfunction in systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591670-000000000-00000

Association of cerebrospinal fluid anti-NR2 glutamate receptor antibodies with diffuse neuropsychiatric systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591670-000000000-00000

Association of IgG anti-NR2 glutamate receptor antibodies in cerebrospinal fluid with neuropsychiatric systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591670-000000000-00000

Serum and cerebrospinal fluid autoantibodies in patients with neuropsychiatric lupus erythematosus. Implications for diagnosis and pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591670-000000000-00000

Autoantibody profile in systemic lupus erythematosus with psychiatric manifestations: a role for anti-endothelial-cell antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591670-000000000-00000

Clinical associations of anti-endothelial cell antibodies in patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591670-000000000-00000

Raised serum S100B protein levels in neuropsychiatric lupus.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591670-000000000-00000

Neuropsychiatric manifestations of systemic lupus erythematosus: the value of anticardiolipin, antigangliosides and antigalactocerebrosides antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591670-000000000-00000

Central nervous system involvement in SLE. Diagnostic profile and clinical features

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591670-000000000-00000

Neuronal and astrocytic damage in systemic lupus erythematosus patients with central nervous system involvement

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591670-000000000-00000

Magnetic resonance imaging in the evaluation of central nervous system manifestations in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591670-000000000-00000

Cerebral and corpus callosum atrophy in systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591670-000000000-00000

Longitudinal analysis of gray and white matter loss in patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591670-000000000-00000

Quantitative magnetic resonance imaging analyses and clinical significance of hyperintense white matter lesions in systemic lupus erythematosus patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591670-000000000-00000

Brain involvement in systemic immune mediated diseases: magnetic resonance and magnetisation transfer imaging study

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591670-000000000-00000

Magnetic resonance angiography in suspected cerebral vasculitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591670-000000000-00000

Central nervous system lupus: a clinical approach to therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591670-000000000-00000

Controlled clinical trial of IV cyclophosphamide versus IV methylprednisolone in severe neurological manifestations in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591670-000000000-00000

Treatment of lupus psychosis with oral cyclophosphamide followed by azathioprine maintenance: an open-label study

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591670-000000000-00000

Can neurologic manifestations of Hughes (antiphospholipid) syndrome be distinguished from multiple sclerosis? Analysis of 27 patients and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591670-000000000-00000

Treatment of lupus with corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591670-000000000-00000

Cyclophosphamide for the treatment of systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591670-000000000-00000

White-matter volume reduction and the protective effect of immunosuppressive therapy in systemic lupus erythematosus patients with normal appearance by conventional magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591670-000000000-00000

Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591670-000000000-00000

Successful treatment of systemic lupus erythematosus cerebritis with intravenous immunoglobulin

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591670-000000000-00000

Efficacy of rituximab (anti-CD20) for refractory systemic lupus erythematosus involving the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591670-000000000-00000

Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: the randomized, double-blind, phase II/III systemic lupus erythematosus evaluation of rituximab trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591670-000000000-00000

Off-label use of rituximab in systemic lupus erythematosus: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591670-000000000-00000

The efficacy of repeated treatment with B-cell depletion therapy in systemic lupus erythematosus: an evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591670-000000000-00000

Marked inflammation in catastrophic longitudinal myelitis associated with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591670-000000000-00000

A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591670-000000000-00000

A systematic review of secondary thromboprophylaxis in patients with antiphospholipid antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591670-000000000-00000

Neuropsychiatric events at the time of diagnosis of systemic lupus erythematosus: An international inception cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11591670-000000000-00000

The incidence and prognosis of central nervous system disease in systemic lupus erythematosus

21 January 2018

1 reference

12 December 2020

Central nervous system involvement in systemic lupus erythematosus: a new therapeutic approach with intrathecal dexamethasone and methotrexate

1 reference

12 December 2020

Association between Lupus Psychosis and Antiribosomal P Protein Antibodies

1 reference

12 December 2020

Neuropsychiatric events in systemic lupus erythematosus: attribution and clinical significance.

1 reference

12 December 2020

The incidence and prevalence of neuropsychiatric syndromes in pediatric onset systemic lupus erythematosus.

1 reference

12 December 2020

Dilemmas in neuropsychiatric lupus.

1 reference

12 December 2020

Cognition, MRS neurometabolites, and MRI volumetrics in non-neuropsychiatric systemic lupus erythematosus: preliminary data

1 reference

12 December 2020

Evidence of central nervous system damage in patients with neuropsychiatric systemic lupus erythematosus, demonstrated by magnetization transfer imaging

1 reference

12 December 2020

Cytokines and chemokines in neuropsychiatric syndromes of systemic lupus erythematosus

1 reference

12 December 2020

Predictors of clinical outcome and radiologic progression in patients with neuropsychiatric manifestations of systemic lupus erythematosus

1 reference

12 December 2020

Neuropsychiatric lupus: clinical and imaging aspects.

1 reference

12 December 2020

Circulating intercellular adhesion molecule-1 and soluble interleukin 2-receptor in patients with systemic lupus erythematosus

1 reference

12 December 2020

Intrathecal cytokines in systemic lupus erythematosus with central nervous system involvement

1 reference

12 December 2020

Treatment combining plasmapheresis and pulse cyclophosphamide in severe systemic lupus erythematosus

1 reference

12 December 2020

Anti-NR2 glutamate receptor antibodies and cognitive function in systemic lupus erythematosus.

1 reference

12 December 2020

Acute psychosis in systemic lupus erythematosus

1 reference

12 December 2020

Neuropsychiatric lupus

1 reference

12 December 2020

Levels of soluble VCAM-1, soluble ICAM-1, and soluble E-selectin during disease exacerbations in patients with systemic lupus erythematosus (SLE); a long term prospective study

1 reference

12 December 2020

Immunosuppression prevents neuronal atrophy in lupus-prone mice: evidence for brain damage induced by autoimmune disease?

1 reference

12 December 2020

Clinical course of cognitive dysfunction in systemic lupus erythematosus.

1 reference

12 December 2020

The neurological manifestations of systemic lupus erythematosus

1 reference

12 December 2020

Neuropsychiatric manifestations in pediatric systemic lupus erythematosus and association with antiphospholipid antibodies.

1 reference

12 December 2020

Intrathecal injection with methotrexate plus dexamethasone in the treatment of central nervous system involvement in systemic lupus erythematosus

1 reference

12 December 2020

The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes

1 reference

12 December 2020

Pulse cyclophosphamide in the treatment of neuropsychiatric systemic lupus erythematosus

1 reference

12 December 2020

The histopathologic associates of neurometabolite abnormalities in fatal neuropsychiatric systemic lupus erythematosus

1 reference

12 December 2020

Pathogenesis of neuropsychiatric systemic lupus erythematosus and potential biomarkers

1 reference

12 December 2020

Neuropsychiatric lupus syndromes: relationship with antiphospholipid antibodies

1 reference

12 December 2020

Pulse Cyclophosphamide for Severe Neuropsychiatric Lupus

1 reference

12 December 2020

Neuropsychiatric manifestations of systemic lupus erythematosus: diagnosis, clinical spectrum, and relationship to other features of the disease

1 reference

12 December 2020

Successful treatment of psychosis secondary to SLE with high dose intravenous immunoglobulin

1 reference

12 December 2020

Neuropsychiatric lupus

1 reference

12 December 2020

Neuropsychiatric systemic lupus erythematosus: lessons learned from magnetic resonance imaging

1 reference

12 December 2020

Accuracy of anti-ribosomal P protein antibody testing for the diagnosis of neuropsychiatric systemic lupus erythematosus: an international meta-analysis

1 reference

12 December 2020

Intravenous immunoglobulin for Guillain-Barré syndrome.

1 reference

12 December 2020

Diffusion-weighted echo-planar MR imaging of CNS involvement in systemic lupus erythematosus

1 reference

12 December 2020

Favorable response to intravenous methylprednisolone and cyclophosphamide in children with severe neuropsychiatric lupus.

1 reference

12 December 2020

Brain pathology in systemic lupus erythematosus

1 reference

12 December 2020

Neuropsychiatric syndromes in patients with systemic lupus erythematosus and rheumatoid arthritis

1 reference

12 December 2020

Expression of S100B protein levels in serum and cerebrospinal fluid with different forms of neuropsychiatric systemic lupus erythematosus

1 reference

12 December 2020

Anti-ribosomal P protein antibodies and neuropsychiatric systemic lupus erythematosus: cross-sectional vs. prospective studies

1 reference

12 December 2020

Risk of coronary heart disease and stroke in a large British cohort of patients with systemic lupus erythematosus

1 reference

12 December 2020

Anti-NMDA receptor autoantibodies in patients with systemic lupus erythematosus and their first-degree relatives

1 reference

12 December 2020

The heterogeneity of neuropsychiatric systemic lupus erythematosus is reflected in lack of association with cerebrospinal fluid cytokine profiles

1 reference

12 December 2020

Increased levels of intercellular adhesion molecule-1 in the serum of patients with systemic lupus erythematosus

1 reference

12 December 2020

Biologic therapy for systemic lupus erythematosus.

1 reference

12 December 2020

Activity of matrix metalloproteinase-9 is elevated in sera of patients with systemic lupus erythematosus

1 reference

12 December 2020

10.2165/11591670-000000000-00000

Identifiers

DOI

1 reference

Dimensions Publication ID

25 August 2017

1039956047

0 references

1 reference